AMN Healthcare reported first quarter 2025 revenue of $690 million, a 16% decrease year-over-year. The company posted a GAAP net loss of $1.1 million and adjusted diluted EPS of $0.45. Results were above the high end of guidance, benefiting from growth in client patient volumes and market adoption of tech-enabled solutions.
First quarter revenue and earnings exceeded guidance expectations.
Consolidated gross margin was better than guidance, and SG&A management improved operating leverage.
Improved bookings, driven by technology and process enhancements, led to sequential growth in locum tenens revenue, with the business expected to return to year-over-year growth.
Strong cash flow from operations of $93 million in Q1 allowed for a $60 million reduction in debt.
For the second quarter of 2025, AMN Healthcare expects consolidated revenue between $645 million and $660 million.
Visualization of income flow from segment revenue to net income